Idiopathic pulmonary fibrosis

Luca Richeldi, Harold R Collard, Mark G Jones

Risultato della ricerca: Contributo in rivistaArticolo in rivista

405 Citazioni (Scopus)

Abstract

Idiopathic pulmonary fibrosis is a prototype of chronic, progressive, and fibrotic lung disease. Healthy tissue is replaced by altered extracellular matrix and alveolar architecture is destroyed, which leads to decreased lung compliance, disrupted gas exchange, and ultimately respiratory failure and death. In less than a decade, understanding of the pathogenesis and management of this disease has been transformed, and two disease-modifying therapies have been approved, worldwide. In this Seminar, we summarise the presentation, pathophysiology, diagnosis, and treatment options available for patients with idiopathic pulmonary fibrosis. This disease has improved understanding of the mechanisms of lung fibrosis, and offers hope that similar approaches will transform the management of patients with other progressive fibrotic lung diseases.
Lingua originaleEnglish
pagine (da-a)1941-1952
Numero di pagine12
RivistaThe Lancet
Volume389
DOI
Stato di pubblicazionePubblicato - 2017

Keywords

  • Medicine (all)

Fingerprint

Entra nei temi di ricerca di 'Idiopathic pulmonary fibrosis'. Insieme formano una fingerprint unica.

Cita questo